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journal homepage: www.e lsev ier .com/ locate /yse izComment on: Cerebrospinal ﬂuid apolipoprotein E concen-
tration decreases after seizure
Dear Editor,
We read with great interest the recent article by Wang et al.
about apolipoprotein E (apoE) concentration in the cerebrospinal
ﬂuid (CSF) of epileptic patients.1 They found that concentrations of
apoE in the CSF of epileptic patients decreased and correlated with
gender, etiological factor and seizure types. We agree that further
studies with a larger sample size and regular follow-ups are
needed to conﬁrm the status of apoE levels in epilepsy. However,
we have some concerns regarding the interpretation of their
ﬁndings proposed by the authors.
ApoE is a glycosylated protein in mammalians characterized by
its wide tissue distribution and multiple biological properties. An
increasing body of evidence points to the association of apoE e4
allele with human diseases such as multiple sclerosis,2 cardiovas-
cular diseases,3 and Alzheimer’s disease.4 As there is limited
permeability of the blood–brain barrier (BBB) to lipoproteins,5 apoE
in CSF is producedwithin BBB and is not derived from plasma.6 As a
result, we can widely assume that apoE in the CSF bears great
potential to serve as a biomarker for many diseases in the central
nervous system.
The ﬁndings byWanget al. that apoE levels decrease in the CSF of
patients with epilepsy are intriguing in that apoE might be
implicated in seizures, as supported by some previous studies.7,8
However, we are concerned about when the CSF samples were
obtained. To validate the hypothesis that the role of apoE as an
important factor in the response to seizure could be reﬂected by
altered concentrations of apoE in the CSF, it would be indispensable
that theCSFsamplesbeobtained immediatelyafterepilepticattacks.
Andonlyonthis condition, the reducedconcentrationsof apoE in the
CSF may be attributed to a phenomenon responding to seizures.
In addition, we are eager to know if there is any statistical
difference regarding the CSF apoE concentrations between
epileptic patients and controls, in males and females respectively.
As mentioned by the authors, there is some gender-dependent
difference in apoE production by both microglia and astrocytes,
while the results shown by Fig. 1 in the article seem contradictory
to the promoting effects of estrogen on apoE production.
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